Vandersarren, LanaBosteels, CedricVanheerswynghels, ManonMoon, JamesEaston, Andrew J.Van Isterdael, GertJanssens, SophieLambrecht, Bart N.van Helden, Mary J.2017-07-242017Vandersarren, Lana, Cedric Bosteels, Manon Vanheerswynghels, James J. Moon, Andrew J. Easton, Gert Van Isterdael, Sophie Janssens, Bart N. Lambrecht, and Mary J. van Helden. 2017. “Epitope mapping and kinetics of CD4 T cell immunity to pneumonia virus of mice in the C57BL/6 strain.” Scientific Reports 7 (1): 3472. doi:10.1038/s41598-017-03042-y. http://dx.doi.org/10.1038/s41598-017-03042-y.http://nrs.harvard.edu/urn-3:HUL.InstRepos:33490866Pneumonia virus of mice (PVM) infection has been widely used as a rodent model to study the closely related human respiratory syncytial virus (hRSV). While T cells are indispensable for viral clearance, they also contribute to immunopathology. To gain more insight into mechanistic details, novel tools are needed that allow to study virus-specific T cells in C57BL/6 mice as the majority of transgenic mice are only available on this background. While PVM-specific CD8 T cell epitopes were recently described, so far no PVM-specific CD4 T cell epitopes have been identified within the C57BL/6 strain. Therefore, we set out to map H2-IAb-restricted epitopes along the PVM proteome. By means of in silico prediction and subsequent functional validation, we were able to identify a MHCII-restricted CD4 T cell epitope, corresponding to amino acids 37–47 in the PVM matrix protein (M37–47). Using this newly identified MHCII-restricted M37–47 epitope and a previously described MHCI-restricted N339–347 epitope, we generated peptide-loaded MHCII and MHCI tetramers and characterized the dynamics of virus-specific CD4 and CD8 T cell responses in vivo. The findings of this study can provide a basis for detailed investigation of T cell-mediated immune responses to PVM in a variety of genetically modified C57BL/6 mice.en-USJournal Article2017-07-2410.1038/s41598-017-03042-y